Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Charmacy Pharmaceutical Co., Ltd. has announced a delay in the publication of its circular related to the New Framework Agreements, now expected to be released by December 13, 2024. The extension is required to finalize certain information, ensuring comprehensive details for investors. This delay might affect stakeholders anticipating updates in the company’s strategic agreements.
For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.